Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Recruiting

Phase 3

Light-Activated AntimicrobialLight-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Sponsor:

Ondine Biomedical Inc.

Code:

NCT06702878

Conditions

Surgical Site Infections

Surgical Wound Infection

Infections

Anti-Infective Agents

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

nasal antimicrobial photodisinfection therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-02. This information was provided to ClinicalTrials.gov by Ondine Biomedical Inc. on 2025-11-17.